On February 12th, Hangzhou Tigermed Consulting (Stock code: 03347) spent approximately 18.52 million yuan to repurchase 350,400 shares of A shares.
Tiger Pharmaceuticals (03347) announced a plan to spend approximately 18.52 million yuan to repurchase 35...
Hangzhou Tigermed Consulting (03347) announced that on February 12, 2025, it will spend approximately 18.52 million yuan to repurchase 350,400 A-shares.
Related Articles
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
